Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Fazio

Showing results (61-70 of 284) with videos related to

Pageof 29
Sort By:
Current Opinion in Cardiology|April 19, 2011
Are statins diabetogenic?Uchechukwu K Sampson, Macrae F Linton, Sergio Fazio
Trends in Cardiovascular Medicine|June 2, 2019
The PCSK9 revolution: Current status, controversies, and future directionsBruce A Warden, Sergio Fazio, Michael D Shapiro
Arteriosclerosis, Thrombosis, and Vascular Biology|November 12, 2002
B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null miceAmy S Major, Sergio Fazio, MacRae F Linton
Current Atherosclerosis Reports|November 22, 2011
Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challengesUchechukwu K Sampson, Sergio Fazio, MacRae F Linton
Current Opinion in Lipidology|March 14, 2002
Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosisJeffrey B Boord, Sergio Fazio, MacRae F Linton
Dermatologic Therapy|October 9, 2013
Oral retinoids and plasma lipidsJessica S Lilley, Macrae F Linton, Sergio Fazio
Journal of Managed Care & Specialty Pharmacy|May 28, 2016
A Systematic Review of PCSK9 Inhibitors Alirocumab and EvolocumabMarian McDonagh, Kim Peterson, Brittany Holzhammer, et al.
Journal of Lipid Research|November 28, 2002
Rapid quantification of murine ABC mRNAs by real time reverse transcriptase-polymerase chain reactionYan Ru Su, MacRae F Linton, Sergio Fazio
American Journal of Physiology. Cell Physiology|October 29, 2004
ApoE-mediated cholesterol efflux from macrophages: separation of autocrine and paracrine effectsDwayne E Dove, Macrae F Linton, Sergio Fazio
Current Opinion in Endocrinology, Diabetes, and Obesity|March 5, 2008
Targeting cardiovascular risk in patients with diabetes: management of dyslipidemiaYasmine S Ali, Macrae F Linton, Sergio Fazio
Pageof 29

Showing results (61-70 of 284) with videos related to

Sort By:
Pageof 29
Current Opinion in Cardiology|April 19, 2011
Are statins diabetogenic?Uchechukwu K Sampson, Macrae F Linton, Sergio Fazio
Trends in Cardiovascular Medicine|June 2, 2019
The PCSK9 revolution: Current status, controversies, and future directionsBruce A Warden, Sergio Fazio, Michael D Shapiro
Arteriosclerosis, Thrombosis, and Vascular Biology|November 12, 2002
B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null miceAmy S Major, Sergio Fazio, MacRae F Linton
Current Atherosclerosis Reports|November 22, 2011
Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challengesUchechukwu K Sampson, Sergio Fazio, MacRae F Linton
Current Opinion in Lipidology|March 14, 2002
Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosisJeffrey B Boord, Sergio Fazio, MacRae F Linton
Dermatologic Therapy|October 9, 2013
Oral retinoids and plasma lipidsJessica S Lilley, Macrae F Linton, Sergio Fazio
Journal of Managed Care & Specialty Pharmacy|May 28, 2016
A Systematic Review of PCSK9 Inhibitors Alirocumab and EvolocumabMarian McDonagh, Kim Peterson, Brittany Holzhammer, et al.
Journal of Lipid Research|November 28, 2002
Rapid quantification of murine ABC mRNAs by real time reverse transcriptase-polymerase chain reactionYan Ru Su, MacRae F Linton, Sergio Fazio
American Journal of Physiology. Cell Physiology|October 29, 2004
ApoE-mediated cholesterol efflux from macrophages: separation of autocrine and paracrine effectsDwayne E Dove, Macrae F Linton, Sergio Fazio
Current Opinion in Endocrinology, Diabetes, and Obesity|March 5, 2008
Targeting cardiovascular risk in patients with diabetes: management of dyslipidemiaYasmine S Ali, Macrae F Linton, Sergio Fazio
Pageof 29